Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Lantheus Holdings, Inc. - Common Stock
(NQ:
LNTH
)
75.28
-0.57 (-0.75%)
Streaming Delayed Price
Updated: 2:33 PM EDT, Apr 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lantheus Holdings, Inc. - Common Stock
< Previous
1
2
...
16
17
18
19
20
21
22
23
Next >
These Were The Five Best And Worst Performing Mid-Cap Stocks In H1 2022
↗
July 24, 2022
Investors who want to make quick returns while having some stability amid the current volatile market environment can go for mid-cap stocks. Let’s take a look at the five best and worst performing...
Via
Talk Markets
Silk Road Medical Stock Clears Key Benchmark, Hitting 90-Plus RS Rating
↗
July 22, 2022
Silk Road Medical stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 69 to 90.
Via
Investor's Business Daily
Why Jim Cramer Says This Stock Is 'Now A Little Over-Valued'
↗
July 21, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Lantheus Holdings Inc (NASDAQ: LNTH) has been a "rocket ship, but it’s now a little over-valued."
Via
Benzinga
Nasdaq Flashes A Stealth Buy Signal: What’s Next?
↗
July 18, 2022
The Nasdaq is now trading above its 20-day exponential moving average.
Via
Talk Markets
7 Best Fidelity ETFs to Buy in July
↗
July 18, 2022
July may be a great time to check out the best Fidelity ETFs, as some top names are currently for sale at bargain valuations.
Via
InvestorPlace
Lantheus's Imaging Agent Can Assess PD-L1 Expression for Immunotherapy In Cancer Patients
↗
June 13, 2022
Via
Benzinga
Recap: Lantheus Holdings Q1 Earnings
↗
April 29, 2022
Lantheus Holdings (NASDAQ:LNTH) reported its Q1 earnings results on Friday, April 29, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
UnitedHealth, Shockwave Lead 5 Healthy Stocks Breaking Out Or Setting Up
↗
June 25, 2022
Shockwave and UnitedHealth lead 5 stocks that are setting up or breaking out.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
June 24, 2022
Gainers Redhill Biopharma (NASDAQ:RDHL) stock moved upwards by 16.4% to $0.89 during Friday's pre-market session. The market value of their outstanding shares is at $47.6 million. As per the press...
Via
Benzinga
7 Hot Stocks to Buy During the Next Market Crash
↗
June 01, 2022
These aren't likely the stocks you think about when you think about hot stocks, but that's what makes them so special.
Via
InvestorPlace
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
↗
May 13, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Lantheus Holdings Doses First Patient in Phase 2 Clinical Trial of NM-01 for NSCLC
↗
May 13, 2022
Lantheus Holdings, Inc. (NASDAQ: LNTH) dosed first patient in a Phase 2 trial evaluating NM-01, its proprietary technetium 99m SPECT imaging agent used to assess PD-L1 expression in cancer cells. NM-01...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022
↗
May 09, 2022
Upgrades
Via
Benzinga
Lantheus Holdings's Return On Capital Employed Overview
↗
May 09, 2022
According to Benzinga Pro, during Q1, Lantheus Holdings (NASDAQ:LNTH) earned $42.96 million, a 206.83% increase from the preceding quarter. Lantheus Holdings also posted a total of $208.88 million in...
Via
Benzinga
Stocks That Hit 52-Week Highs On Monday
↗
May 02, 2022
Monday's session saw 22 companies set new 52-week highs.
Via
Benzinga
Market X-Ray – The Story Behind The Numbers
↗
April 30, 2022
The market X-ray shows that bonds have been the most resilient of the major indices so far this year. In years past, bonds would be showing a small gain during a turbulent market, but they are down 10%...
Via
Talk Markets
Earnings Scheduled For April 29, 2022
↗
April 29, 2022
Companies Reporting Before The Bell • Weyerhaeuser (NYSE:WY) is projected to report quarterly earnings at $1.19 per share on revenue of $2.93 billion.
Via
Benzinga
Lantheus Holdings's Earnings: A Preview
↗
April 28, 2022
Lantheus Holdings (NASDAQ:LNTH) is set to give its latest quarterly earnings report on Friday, 2022-04-29. Here's what investors need to know before the announcement. Analysts estimate that Lantheus...
Via
Benzinga
Establishment Labs Stock Clears Technical Benchmark, Hitting 90-Plus RS Rating
↗
April 20, 2022
Establishment Labs stock cleared a key performance benchmark, with its Relative Strength Rating jumping to 92, up from 87 the day before.
Via
Investor's Business Daily
Inspire Medical Systems Stock Scores Relative Strength Rating Upgrade
↗
April 20, 2022
Inspire Medical System stock reached an key technical benchmark, seeing its Relative Strength (RS) Rating jumping to 91.
Via
Investor's Business Daily
Lantheus Holdings Q1 2022 Earnings Conference Call On April 29, 2022 At 08:00 AM ET
↗
April 20, 2022
Lantheus Holdings (NASDAQ:LNTH) will host a conference call at 08:00 AM ET on April 29, 2022, to discuss Q1 2022 earnings results.
Via
Benzinga
Dexcom Stock Shows Market Leadership With Jump To 86 RS Rating
↗
March 30, 2022
Dexcom shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 86.
Via
Investor's Business Daily
This Company Is Making Progress In Its Fight Against Rare, Terminal Cancers
↗
March 22, 2022
Photo by National Cancer Institute on Unsplash
Via
Benzinga
Stocks That Hit 52-Week Highs On Thursday
↗
April 07, 2022
On Thursday, 75 stocks made new 52-week highs. Interesting Highlights From Today's 52-Week Highs: The largest company by market cap to hit a new 52-week high...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
March 18, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Lantheus Sees Composite Rating Move Up To 96; Stock Rockets To New Highs
↗
February 28, 2022
Medical imaging Lantheus stock saw an improvement in its IBD SmartSelect Composite Rating Monday, from 93 to 96.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Friday's Intraday Session
↗
February 25, 2022
Gainers Aerie Pharmaceuticals (NASDAQ:AERI) shares increased by 28.1% to $7.56 during Friday's regular session. Trading volume for Aerie Pharmaceuticals's stock is...
Via
Benzinga
Stocks That Hit 52-Week Highs On Thursday
↗
March 03, 2022
On Thursday, 95 companies set new 52-week highs. Interesting Highlights From Today's 52-Week Highs: The largest company by market cap to break to a new 52-week high...
Via
Benzinga
93 Biggest Movers From Friday
↗
February 28, 2022
Gainers Inspirato Incorporated (NASDAQ: ISPO) shares surged 50.5% to close at $54.90. Guardforce AI Co., Limited (NASDAQ: GFAI) jumped 45.4% to settle at $0.5979 on Friday. EF...
Via
Benzinga
88 Biggest Movers From Yesterday
↗
February 25, 2022
Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren recently announced a $12 million private placement. Indonesia Energy Corporation...
Via
Benzinga
< Previous
1
2
...
16
17
18
19
20
21
22
23
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.